Evidence mapPaperPMID 41207936Full record

ReviewAdvances in experimental medicine and biology2026

Comprehensive Approaches to Protein Detection and Analysis in Mycobacterium tuberculosis.

Parissa Farnia, Ali Akbar Velayati, Jalaledin Ghanavi, Poopak Farnia

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Parissa FarniaShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran. farnia@theaasm.org.
Ali Akbar VelayatiShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran.
Jalaledin GhanaviShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran.
Poopak FarniaShahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Comprehensive strategies for detecting and analyzing proteins in Mycobacterium tuberculosis (Mtb) integrate advanced experimental and computational approaches to deepen understanding of the bacterium's biology, pathogenesis, and mechanisms of drug resistance. Recent technological advances have refined genome annotations by identifying novel protein-coding regions and improving existing gene models. Utilizing diverse fractionation techniques combined with mass spectrometry, proteins localized to distinct cellular compartments, including the cell wall, membranes, and cytoplasm, can be profiled, providing critical insights into their spatial organization and functional roles. Comparative proteomic analyses across multiple Mtb strains have uncovered both unique protein variants and conserved elements, shedding light on bacterial adaptation and virulence strategies. Mapping protein interaction networks has revealed essential pathways governing metabolism and survival, highlighting the intricate coordination of proteins that underpin Mtb pathogenicity. Furthermore, the integration of machine learning and bioinformatics tools has significantly advanced the prediction of protein functions, posttranslational modifications, and contributions to drug resistance, thereby enabling the prioritization of promising targets for therapeutic intervention. Collectively, these modern methodologies offer a detailed and dynamic portrait of the Mtb proteome, facilitating the discovery of novel biomarkers, drug targets, and vaccine candidates. This comprehensive knowledge base is vital for guiding the development of improved diagnostic tools, effective treatments, and, ultimately, strategies to control and eradicate tuberculosis.

Indexed as

Bacterial ProteinsMycobacterium tuberculosisProteomeProteomicsTuberculosisComputational BiologyHumansBacterial ProteinsProteomeLiquid chromatographyMass spectrometryMycobacterium tuberculosisProtein detectionProtein profilingSDS-PAGE

Identifiers

PMID41207936

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.